Johnson & Johnson Announces CE Mark for CEREGLIDE™ 42, CEREGLIDE™ 57, CEREGLIDE™ 71 and INNERGLIDE™ 7 28 May 2026
Johnson & Johnson Highlights Favorable 12-Month Interim Results for the VARIPULSE Platform at EHRA 2026 01 May 2026
